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ABSTRACT 
Conventional oral drug delivery systems supply an instantaneous release of drug, which cannot control the release of the drug and effective concentration at 
the target site. This kind of dosing pattern may result in constantly changing, unpredictable plasma concentrations. Drugs can be delivered in a controlled 
pattern over a long period of time by the process of osmosis. Osmotic devices are the most promising strategy based systems for controlled drug delivery. 
They are the most reliable controlled drug delivery systems and could be employed as oral drug delivery systems. Various patents available for osmotic drug 
delivery system like Rose-Nelson pump, Higuchi leeper pump, Higuchi Theeuwes pump, Elementary Osmotic pump etc. ODDS are useful for poorly soluble 
drug, for pulsatile drug release, zero order release. Various techniques available for preparation of ODDS include push pull osmotic Pump, osmotic Brusting 
osmotic pump, liquid oral osmotic system, sandwiched osmotic tablets , delayed delivery osmotic device, monolithic osmotic System and controlled porosity 
osmotic Pump. Osmotically controlled oral drug delivery systems utilize osmotic pressure for controlled delivery of active agents. These systems can be 
utilized for systemic as well as targeted delivery of drugs. The release of drugs from osmotic systems is governed by various formulation factors such as 
solubility and osmotic pressure of the core components, size of the delivery orifice, and nature of the rate-controlling membrane. In this Paper mainly focused 
on the Osmotic System with example, the basic component of osmotic system and evaluation parameter of the osmotic drug delivery system. 
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INTRODUCTION 
Oral controlled release (CR) systems continue to be the most 
popular amongst all the drug delivery systems. Because of 
the  pharmaceutical agents  can  be  delivered  in  a  controlled 
pattern over a long period. Conventional oral drug delivery 
systems  supply  an  instantaneous  release  of  drug,  which 
cannot  control  the  release  of  the  drug  and  effective 
concentration at the target site. The bioavailability  of drug 
from these formulations may vary significantly, depending on 
factors  such  as  physico-chemical  properties  of  the  drug, 
presence of excipients, various physiological factors such as 
the  presence  or  absence  of  food,  pH  of  the  GI  tract,  GI 
motility etc. To overcome this limitation a number of design 
options are available to control or modulate the drug release 
from a dosage form. Majority of per oral dosage form fall in 
the  category  of  matrix,  reservoir  or  osmotic  system. 
Reservoir systems have a drug core surrounded coated by the 
rate controlling membrane; there has been increasing interest 
in  the  development  of  osmotic  devices  over  the  past  2 
decades. Drug delivery from this system is not influenced by 
the different physiological factors within the gut lumen, and 
the release characteristics can be predicted easily  from the 
known  properties  of  the  drug  and  the  dosage  form.  Drug 
release from these systems is independent of pH and other 
physiological parameter to a large extent and it is possible to 
modulate  the  release  characteristic  by  optimizing  the 
properties of drug and system. the oral osmotic pumps have 
certainly came a long way and the available products on this 
technology and number of patent granted in the last few years 
makes it presence felt in the market.
1, 2 
Osmotically  Controlled  Drug  Delivery  System  (OCDDS) 
Osmotic  devices  are  the  most  reliable  controlled  drug 
delivery systems (CDDS) and can be employed as oral drug 
delivery  systems.  Osmotic  pressure  is  used  as  the  driving 
force  for  these  systems  to  release  the  drug  in  a  controlled 
manner. Osmotic pump tablet (OPT) generally consists of a 
core including the drug, an osmotic agent, other excipients 
and semi permeable membrane coat.
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ADVANTAGES
3, 4 
·  Easy to formulate and simple in operation. 
·  Improve patient compliance with reduced frequency. 
·  Prolonged  therapeutic  effect  with  uniform  blood 
concentration.  
·  They typically give a zero order release profile after an 
initial lag. 
·  Deliveries may be delayed or pulsed if desired. 
·  Drug  release  is  independent  of  gastric  pH  and 
hydrodynamic condition. 
·  They are well characterized and understood. 
·  The release mechanisms are not dependent on drug. 
·  A high degree of in-vitro and in-vivo correlation (IVIVC) 
is obtained in osmotic systems. 
·  The  rationale  for  this  approach  is  that  the  presence  of 
water in git is relatively constant, at least in terms of the 
amount  required  for  activation  and  controlling 
osmotically base technologies. 
·  Higher  release  rates  are  possible  with  osmotic  systems 
compared  with  conventional  diffusion-controlled  drug 
delivery systems. 
·  The release from osmotic systems is minimally affected 
by the presence of food in gastrointestinal tract. 
·  The release rate of osmotic systems is highly predictable 
and can be programmed by modulating the release control 
parameters. 
DISADVANTAGES
3, 4 
·  Dose dumping. 
·  Rapid development of tolerance. 
·  Retrieval therapy is not possible in the case of unexpected 
adverse events. 
·  Expensive. 
·  If the coating process is not well controlled there is a risk 
of film defects, which results in dose dumping. 
·  Size hole is critical. 
OSMOSIS AND ITS PRINCIPLE
1  
Osmotic systems utilize the principle of osmotic pressure for 
the delivery of drugs. Conventionally, osmosis can be defined Harnish Patel et al. IRJP 2012, 3 (4) 
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as the net movement of water across a selectively permeable 
membrane driven by a difference in osmotic pressure across 
the  membrane  that  allows  passage  of  water  but  cast  offs 
solute  molecules  or  ions  .  The  first  osmotic  effect  was 
reported  by  Abbe  Nollet  in  1748.  Later  in  1877,  Pfeffer 
performed an experiment using semi-permeable membrane to 
separate sugar solution from pure water. He showed that the 
osmotic pressure of the sugar solution is directly proportional 
to the solution concentration and the absolute temperature. In 
1886,  Vant  Hoff  identified  an  underlying  proportionality 
between osmotic pressure, concentration and temperature. He 
revealed  that  osmotic  pressure  is  proportional  to 
concentration  and  temperature  and  the  relationship  can  be 
described by following equation.  
Π = Ø c RT 
Where, Π = Osmotic pressure, Ø = osmotic coefficient, c = 
molar concentration, R = gas constant, T = Absolute 
temperature. 
Osmotic pressure is a colligative property, which depends on 
concentration of solute that contributes to osmotic pressure. 
Solutions of different concentrations having the same solute 
and solvent system exhibit an osmotic pressure proportional 
to their concentrations. Thus a constant osmotic pressure, and 
thereby  a  constant  influx  of  water  can  be  achieved  by  an 
osmotic delivery system that results in a constant zero order 
release rate of drug. 
CLASSIFICATION OF OSMOTIC DRUG DELIVERY 
SYSTEM 
Implantable
4 
1.  The Rose and Nelson Pump  
2.  Higuchi Leeper Pump  
3.  Higuchi Theuwes pump  
4.  Implantable Mini osmotic pump  
Oral osmotic Pump
4 
Single chamber osmotic pump: Elementary osmotic pump  
Multi  chamber  osmotic  pump:  Push  pull  osmotic  pump, 
Osmotic pump with non expanding second chamber  
Specific types: Controlled porosity osmotic pump, Osmotic 
bursting osmotic pump,   Liquid OROS, Delayed Delivery 
Osmotic  device,  Telescopic  capsule,  OROS-CT  (colon 
targeting),  sandwiched  oral  therapeutic  system,  Osmotic 
pump  for  insoluble  drugs,  Monolithic  osmotic  system  and 
OSMAT. 
Rose  and  Nelson  were  two  Australian  physiologists 
interested in the delivery  of drugs to the gut of sheep and 
cattle. Their pump was never patented. The pump consisted 
of three chambers: a drug chamber, a salt chamber containing 
excess solid salt, and a water chamber. The drug and water 
chambers are separated by a rigid semi permeable membrane. 
The  difference  in  osmotic  pressure  across  the  membrane 
moves water from the water chamber into the salt chamber. 
The  volume  of  the  salt  chamber  increases  because  of  this 
water flow, which distends the latex diaphragm separating the 
salt  and  drug  chambers,  thereby  pumping  drug  out  of  the 
device. The pumping rate of the Rose-Nelson pump is given 
by the Equation 
dMt /dt = (dv/dt) C ………….. (1) 
Where, dMt/dt is the drug release rate, dv/dt is the volume 
flow of water in to salt chamber, C is the concentration of 
drug in the drug chamber.
5 
Alza  Corporation  represented  the  first  series  of  Rose  and 
Nelson  pump.  Which  is  illustrated  in  figure  1  there  is  no 
water  chamber  in  Higuchi  Leeper  pump  and  the  device 
activate  after  penetration  of  water  inside  the  device  from 
surrounding  environment.  Higuchi  Leeper  pump  is  widely 
used  for  veterinary  use.  This  type  of  pump  is  either 
swallowed or implanted in the body of animal for delivery of 
antibiotic or growth hormones. Higuchi Leeper pump consist 
of rigid housing and semi permeable membrane. A layer of 
low  melting  waxy  solid,  such  as  microcrystalline  paraffin 
wax is used in place of elastic diaphragm to separate the drug 
and osmotic chamber. Recent modification in Higuchi-Leeper 
pump  accommodated  pulsatile  drug  delivery.  The  pulsatile 
release was achieved by the production of a critical pressure 
at which the delivery orifice opens and releases the drug.
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Figure 1 Higuchi Leeper Pump 
 
Higuchi Theuwes pump is illustrated in figure 2 in this device 
the rigid housing is made up of semi permeable membrane 
which  is  enough  strong  to  with  stand  with  the  pumping 
pressure  developed  inside  the  device  due  to  permeation  of 
water. The drug is loaded only to the prior of application of 
device. The release of drug from device can be controlled by 
salt used in chamber, the permeability characteristic of outer 
membrane  and  orifice.  Osmotic  pump  of  this  form  are 
available under trade name Alzet. A mixture of citric acid and 
sodium  bi  carbonate  in  salt  chamber  in  presence  of  water 
generate carbon di -oxide gas. Which exert a pressure on the 
elastic diaphragm, eventually delivers the drug from device.
1  
 
 
Figure 2 Higuchi Theuwes Pump 
 
Implantable  Mini  osmotic  pump  shown  in  figure  3  it  is 
composed of three concentric layers-the drug reservoir, the 
osmotic  sleeves  and  the  rate  controlling  semi  permeable 
membrane. The additional component called flow moderator 
is  inserted  into  the  body  of  the  osmotic.  The  inner  most 
compartment  of  drug  reservoir  which  is  surrounded  by  an 
osmotic sleeve, a cylinder containing high concentration of 
osmotic  agent.  The  osmotic  sleeve  is  covered  by  a  semi 
permeable membrane when the system is placed in aqueous 
environment water enters the sleeve through semi permeable 
membrane,  compresses  the  flexible  drug  reservoir  and 
displaces  the  drug  solution  through  the  flow  moderator. 
These  pumps  are  available  with  variety  of  delivery  rates 
between 0.25 to 10ml per hour and delivery duration between 
one day and four weeks.
1 Harnish Patel et al. IRJP 2012, 3 (4) 
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Figure 3 Implantable osmotic pump 
 
Elementary osmotic pump 
Elementary osmotic pump works on the same mechanism as 
the  impala  table  pumps  it  is  simplest  possible  form  of 
osmotic pump as it does not require special equipment and 
technology .This device was further simplification of Higuchi 
–  Theeuwes  pump.  It  was  developed  in  the  year  1975  by 
Theeuwes  (Santus  et  al,1995)  The  EOP  consist  of  single 
layered tablet core containing a water soluble drug with or 
without  other  osmotic  agent  .A  semi  permeable  membrane 
surrounds the tablet core. When such a system is swallowed 
water from the GIT enter through the membrane in the core, 
the  drug  dissolved  and  the  drug  solution  is  pumped  out 
through the exit orifice. This process continues at a constant 
rate  until  the  entire  solid  drug  inside  the  tablet  has  been 
dissolved drug continues to be delivered but at a declining 
rate until the osmotic pressure between outside environment 
and saturated drug solution. Normally the EOP delivers 60 - 
80% of its content at a constant rate and there is a short lag 
time of 30- 60 min as the system hydrates before zero order 
drug release from the EOP is obtained.
4, 6 
Pramod Kumar et al
7 carried out the study of Elementary 
osmotic pump (EOP) for highly water soluble drug tramadol 
hydrochloride  (TRH)  was  developed  and  evaluated.  Target 
release  profile  was  selected  and  different  variables  were 
optimized  to  achieve  the  same.  Formulation  variables  like 
levels of swellable polymer (10-21.87 %) and plasticizer (0-
20% w/w of polymer), and coat thickness of semi permeable 
membrane (SPM) were found to affect the drug release from 
the  developed  formulations.  TRH  release  was  directly 
proportional to the level of plasticizer and osmotic pressure 
generated by osmotic agent but inversely proportional to the 
level of swellable polymer within the core and coat thickness 
of  SPM.  Drug  release  from  developed  formulations  was 
independent of pH and agitation intensities of release media. 
Burst strength of the exhausted shells increased with increase 
in  coat  thickness  but  decreased  with  increase  in  level  of 
plasticizer. The in-vitro results of the developed formulations 
were  compared  with  performance  of  standard  marketed 
formulation  of  TRH.  The  developed  formulation  provided 
more prolonged and controlled TRH release as compared to 
marketed  formulation.  The  manufacturing  procedure  was 
found to be stable during six months of accelerated stability 
study. 
Push pull osmotic pump 
Push pull osmotic pump is a modified EOP (Vyas et al, 2001; 
Barclay et al, 1987) through, which it is possible to deliver 
both poorly water-soluble and highly water soluble drugs at a 
constant  rate.  This  system  resembles  a  standard  bilayer 
coated tablet. One layer (depict as the upper layer) contains 
drug in a formulation of polymeric, osmotic agent and other 
tablet excipients. This polymeric osmotic agent has the ability 
to form a suspension of drug in situ. When this tablet later 
imbibes water, the other layer contains osmotic and colouring 
agents,  polymer  and  tablet  excipients.  These  layers  are 
formed and bonded together by tablet compression to form a 
single bilayer core. The tablet core is then coated with semi 
permeable membrane. After the coating has been applied, a 
small  hole  is  drilled  through  the  membrane  by  a  laser  or 
mechanical drill on the drug layer side of the tablet.
4 
Suresh  P.  Vyas  et  al
8  carried  out  the  study  of  An  oral 
osmotic  system  which  can  deliver  theophylline  and 
salbutamol  sulphate  simultaneously  for  extended  period  of 
time was developed and characterized in a view to reduce the 
problems  associated  with the  multidrug  therapy  of  asthma. 
Simple  controlled  porosity  osmotic  pump  contained  both 
drugs  (in  freely  soluble  form)  did  not  provide  satisfactory 
extended  release  of  theophylline.  A  modified  two-layered, 
push–pull osmotic system was developed by using the basic 
designs  of  various  oral  osmotic  pumps,  such  as  controlled 
porosity  osmotic  pump  (CPOP),  elementary  osmotic  pump 
(EOP)  and  push–pull  osmotic  pump  (PPOP).  Scanning 
electron microscopy  of  cellulose acetate coating membrane 
after dissolution revealed that 25% (w/w) of sorbitol can be 
used  as  an  optimized  concentration  of  pore  forming  agent 
with  25%  (w/w)  of  plasticizer,  which  was  kept  constant. 
Formulations  were  initially  developed  for  theophylline  and 
the  release  was  optimized  by  using  two  different  soluble 
forms  of  theophylline  with  varying  amount  of  hydrophilic 
polymer  mixture  in  upper  layer  and  polyethylene  oxide 
(expandable hydrogel) in lower layer. Further, the release of 
salbutamol sulphate was optimized by keeping the drug in 
upper or lower layer or both layers. In vitro release studies 
showed satisfactory controlled release profiles of both drugs. 
The release profiles of both drug statistically compared with 
respective  marketed  controlled  release  formulations.  An 
optimized  system  was  selected  to  study  the  effect  of 
concentration of pore forming agent and orifice diameter on 
the release of both drugs. 
Osmotic pump with non expanding second chamber 
The  second  category  of  multi-chamber  devices  comprises 
system  containing  a  non-expanding  second  chamber.  This 
group can be divided into two sub groups, depending on the 
function of second chamber. In one category of these devices, 
the second chamber is used to dilute the drug solution leaving 
the devices. This is useful because in some cases if the drug 
leaves the oral osmotic devices a saturated solution, irritation 
of GI tract is a risk. This type of devices consist of two rigid 
chamber,  the  first  chamber  contains  a  biologically  inert 
osmotic  agent,  such  as  sugar  or a  simple  salt like  sodium 
chloride, the second chamber contains the drug. In use water 
is drawn into both the chamber through the surrounding semi 
permeable membrane. The solution of osmotic agent formed 
in the first chamber then passes through the connecting hole 
to the drug chamber where it mixes with the drug solution 
before exiting through the micro porous membrane that form 
a part of wall surrounding the chamber. The device could be 
used to deliver relatively insoluble drugs.
4 
Miscellaneous 
Controlled porosity osmotic pump 
The  controlled-porosity  osmotic  pump  tablet  concept  was 
developed as an oral drug delivery system by Zentner et al 
(1985, 1991), Zentner and Rork (1990), Appel and Zentner 
(1991), and Mc Celland et al. (1991). The controlled-porosity 
osmotic  pump  tablet  (CPOP)  is  a  spray-coated  or  coated 
tablet  with a  semi  permeable  membrane  (SPM)  containing 
leachable pore forming agents. They do not have any aperture 
to  release  the  drugs;  drug  release  is  achieved  through  the Harnish Patel et al. IRJP 2012, 3 (4) 
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pores, which are formed in the semi permeable wall in situ 
during  the  operation.  In  this  system,  the  drug,  after 
dissolution inside the core, is released from the osmotic pump 
tablet  by  hydrostatic  pressure  and  diffusion  through  pores 
created by the dissolution of pore formers incorporated in the 
membrane  (Figure  4).  The  hydrostatic  pressure  is  created 
either by an osmotic agent or by the drug itself or by a tablet 
component, after water is imbibed across the semi permeable 
membrane.
3, 9 
 
 
Figure 4 CPOP tablet before and after dissolution studies 
 
Rabiu Yakubu et al.
10  carried out the study of the purpose 
of  this  study  was  to  design  a  24-hour  controlled  porosity 
osmotic  pump  system  that  utilizes  polyvinyl  pyrrolidone 
(PVP)  as  an  osmotic-suspending/release  retarding  agent  of 
drugs.  Methods:  Osmotic  tablet  cores  containing  various 
ratios  of  ketoprofen  and  PVP  were  prepared  by  wet 
granulation and initially spray coated with similar solution of 
cellulose  acetate.  A  formulation  containing  ketoprofen  and 
PVP at a ratio of 1:7 was selected for further studies. Results: 
The final formulation containing PVP K-30 in the tablet core 
augmented the release of ketoprofen (poorly  water-soluble) 
up to 90% over 24 hours much higher than either PVP K-25 
or  PVP  K-90  and  retarded  the  release  of  pseudoephedrine 
HCl (highly water-soluble) up to 18 hours. Conclusion: This 
study proposed the dual use of PVP in osmotic pump systems 
containing solids to modulate the release of either poorly or 
highly water-soluble drug. 
Liquid OROS
4 
Liquid  OROS  are  designed  to  deliver  drugs  as  liquid 
formulations and  combine  the  benefits  of  extended release 
with high bioavailability. They are of three types 
•  L OROS hard cap, 
•  L OROS soft cap, 
•  Delayed liquid bolus delivery system 
Delayed Delivery Osmotic device 
 Because  of their semi permeable walls, an osmotic device 
inherently  show  lag  time  before  drug  delivery  begins. 
Although this characteristic is usually cited as a disadvantage, 
it can be used advantageously. The delayed release of certain 
drug  (drugs  for  early  morning  asthma  or arthritis)  may  be 
beneficial. The following text describe other means to further 
delay drug release.
4 
Telescopic Capsule for Delayed Release 
This device consists of two chambers, the first contains the 
drug and an exit port, and the second contains an osmotic 
engine.  A  layer  of  wax  like  material  separates  the  two 
sections. To assemble the delivery device, the desired active 
agent  is  placed  into  one  of  the  sections  by  manual  or 
automated  fill  mechanism.  The  bilayer  tablet  with  the 
osmotic  engine  is  placed  into  a  completed  cap  part  of  the 
capsule  with  the  convex  osmotic  layer  pointed  in  to  the 
closed end of the cap and the barrier into the closed end of 
the  cap  and  the  barrier  layer  exposed  towards  the  cap 
opening. The open end of the filled vessel is fitted inside the 
open  end  of  the  cap,  and  the  two  pieces  are  compressed 
together until the cap, osmotic bilayer tablet and vessel fit 
together  tightly.  As  fluid  is  imbibed  the  housing  of  the 
dispensing  device,  the  osmotic  engine  expand  and  exerts 
pressure  on  the  slidable  connected  first  and  second  wall 
sections.
4 
OROS-CT 
OROS-CT (Alza corporation) is used as a once or twice a day 
formulation for targeted delivery of drugs to the colon. The 
OROS-CT  can  be  a  single  osmotic  agent  or  it  can  be 
comprised of as many as five to six push pull osmotic unit 
filled in a hard gelatin capsule. After coming in contact with 
the gastric fluids, gelatin capsule dissolved and the enteric 
coating prevents entry of fluids from stomach to the system 
as  the  system  enters  into  the  small  intestine  the  enteric 
coating dissolves and water is imbibed into the core thereby 
causing  the  push  compartment to  swell.  At  the  same  time 
flowable  gel  is  formed  in  the  drug  compartment,  which  is 
pushed  out  of  the  orifice  at  a  rate,  which  is  precisely 
controlled,  by  the  rate  of  water  transport  across  the  semi 
permeable membrane.
11 
Sandwiched oral therapeutic system 
It is composed of polymeric push layer sandwiched between 
two drug layers with two delivery orifices. When placed in 
the aqueous environment. The middle push layer containing 
the swelling agents, swells and the drug is released from the 
delivery orifices. The advantage of this type of system is that 
the drug is released from the two orifices situated on opposite 
sides of the tablet and thus SOTS can be suitable for drugs 
prone to cause local irritation of the gastric mucosa.
4, 12 
Lipid osmotic pump 
Merk  describes  an  osmotic  pump  for  the  lipid  delivery  as 
shown in the figure. The device concerns an osmotic agent 
for dispensing beneficial active agent that has poor solubility 
in  water.  The  core  of  the  system  comprises  a  beneficial 
amount of a substantially water- insoluble active agent, which 
is  lipid  soluble  or  lipid-  wettable;  a  sufficient  amount  of 
water  insoluble  lipid  carrier,  which  is  liquid  at  the 
temperature of use to dissolve or suspend the drug and agent 
to ensure the release of the lipid carrier of the drug from the 
pump (God billion et al, 1985) The water insoluble wall is 
micro  porous  and  is  wetted  by  lipid  carrier. The  device  is 
prepared by first dissolving the drug of interest in the lipid 
vehicle. The osmogent (Sodium chloride) is dispersed in the 
melted lipid and then quenched-cool to form a lump that are 
broken and made into tablet. The micro porous is coated at a 
moderate flow of unheated ambient air.
9 
Multiparticulate osmotic pump 
MPOP consist of pellets comprises of drug with or without 
osmotic  agent,  which  are  coated  with  a  semipermiable 
membrane.  When  this  system  comes  in  contact  with  the 
aqueous environment, water penetrates in the core and forms 
a saturated solution of soluble component (Schultzew et al, 
1997).  The  osmotic  pressure  difference  results  in  rapid 
expansion  of  the  membrane,  leading  to  the  formation  of 
pores. The osmotic agent and the drug released through the 
pores  according  to  zero  order  kinetics.  The  lag  time  and 
dissolution rate were found to be dependent on the coating 
level and the osmotic properties of the dissolution medium.
11  
Monolithic osmotic system 
It constitutes a simple dispersion of  water-soluble agent in 
polymer matrix. When the system comes in contact in with 
the  aqueous  environment  water  imbibitions  by  the  active 
agents  takes  place  rupturing  the  polymer  matrix  capsule 
surrounding  the  drug,  thus  liberating  it  to  the  outside 
environment (Mishra et al, 2006). Initially this process occurs Harnish Patel et al. IRJP 2012, 3 (4) 
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at  the  outer  environment  of  the  polymeric  matrix,  but 
gradually  proceeds  towards  the  interior  of  the  matrix  in  a 
serial fashion. However this system fails if more than 20 –30 
volume per liter of the active agents is incorporated in to the 
device as above this level, significant contribution from the 
simple leaching of the substance take place.
4,13 
OSMAT 
It is a novel osmotically driven matrix system, which utilizes 
the  hydrophilic  polymers  to  swell,  and  gel  in  aqueous 
medium forming a semipermiable membrane in-situ releases 
from  such  a  matrix  system  containing  an  osmogen  could, 
therefore be modulated by the osmotic phenomenon. Osmat 
thus judiciously combines both matrix osmotic characteristics 
resulting in a quantum improvement in drug delivery  from 
swellable  matrix  system.  Osmat  produces  controlled  drug 
release  with  adequate  delivery  rates  in  an  agitation  in 
dependent manner. Thus osmat represents simple, versatile, 
and  easy  to  fabricate  osmotically  driven  controlled  drug 
delivery system based upon low cot technology.
4 
Basic components of osmotic systems
1 
Drug 
All drugs are not suitable candidate for osmotic system as 
prolong action medication .Drug with biological half life > 12 
hr e.g.: Diazepam and drug which have very short half life 
i.e.  <1  hr  e.g.  Penicillin  G,  furosemide  are  not  suitable 
candidate  for  osmotic  controlled release.  Drug  which have 
biological half-life in between 1 – 6 hrs and which is used for 
prolonged  cure  of  diseases  are  ideal  applicant  for  osmotic 
systems.  A  variety  of  drug  candidates  such  as  Diltiazem 
HCl32,  Carbamazepine,  Metoprolol33,  Oxprenolol, 
Nifedipine34,  Glipizide35  etc.  are  formulated  as  osmotic 
delivery. 
Semi permeable membrane
14, 15   
There  are  various  types  of  polymers  are  used  as  semi 
permeable membrane .the selection of polymer is based on 
the solubility of drug as well as amount and rate of drug to be 
released  from  pump.  Cellulose  acetate  is  commonly  used 
polymer for preparation of semi permeable for osmotic pump 
devices. Different grades of cellulose acetate with different 
acetyl content usually 32% and 38% are mostly used. A part 
from cellulose derivative, some other polymers such as poly 
(vinyl  methyl)  ether  copolymer  ,  poly  (orthoester)  ,poly 
acetals  and  selectively  permeable  poly(glycolic  acid)  and 
poly(lactic  acid)  derivatives,  Eudragit  can  be  used  as  semi 
permeable  film  forming  materials.  The  permeability  is  the 
most important criteria for the selection of semi permeable 
membrane. Therefore, the polymeric membrane selection is 
important  to  osmotic  delivery  formulation.  The  membrane 
must have certain performance criteria such as:  
•  It  should  be  adequately  thick  to  withstand the  pressure 
generated within the device.  
•  It  should  have  enough  wet  strength  and  water 
permeability 
•  It should be biocompatible.  
•  It should be rigid and non-swelling  
The reflection coefficient and leakiness of the osmotic agent 
should approach the limiting value of unity. Unfortunately, 
polymer  membranes  that  are  more  permeable  to  water  are 
also, in general more permeable to the osmotic agent. 
Plasticizers 
Plasticizers have a crucial role to play in the formation of a 
film coating and its ultimate structure. Plasticizers increases 
the  workability  ,flexibility  and  permeability  of  fluids 
.generally from 0.001 to 50 parts of plasticizer or a mixture of 
plasticizers are incorporated in to 100 part of wall forming 
material.  They  can  change  viscous-elastic  behavior  of 
polymers and these changes may affect the permeability of 
the  polymeric  films.  Plasticizers  can have  a  marked  effect 
both quantitatively and qualitatively on the release of active 
materials from modified release dosage forms where they are 
incorporated into the rate-controlling membrane36. Some of 
the  plasticizers  used  are  as  below:  Polyethylene  glycols, 
Glycolate,  Glycerolate,  myristates,  Ethylene  glycol 
monoacetate; and diacetate- for low permeability, Tri ethyl 
citrate,  Diethyl  tartarate  or  Diacetin-  for  more  permeable 
films. 
Osmotic agent
3, 16, 17  
Osmogent are essential ingredient of osmotic pump, usually 
is  ionic  compounds  consisting  of  either  inorganic  salts  or 
hydrophilic  polymers  and  carbohydrates.  Generally 
combination of osmogent is used to achieve desired osmotic 
pressure within the device. Some of the osmotic agents that 
can be used for such systems are classified below. Different 
type  of  osmogents  can  be  used  for  such  systems  are 
categorized as  
•  Inorganic  water-soluble  osmogents:  Magnesium 
sulphate,  Sodium  chloride,  Sodium  sulphate
  16, 
Potassium chloride 
17, Sodium bicarbonate  
•  Organic  polymer  osmogents:  Sodium  carboxy  methyl 
cellulose,  Hydroxy  propyl  methyl  cellulose, 
Hydroxyethylmethylcellulose,  Methylcellulose, 
Polyethylene oxide, polyvinyl pyrollidine. 
Wicking agent 
The wicking agents are those agents which help to increase 
the  contact  surface  area  of  the  drug  with  the  incoming 
aqueous fluid. The use of the wicking agent help to enhance 
the rate of drug released from the orifice of the drug. The 
examples are colloidal silicon dioxide, PVP & Sodium laryl 
sulphate. 
Pore former
18 
These  agents  are  particularly  used  in  the  development  of 
pump  for  poorly  water  soluble  drugs  and  in  controlled 
porosity tablets. These agents cause the formation of micro 
porous membrane .The micro porous wall may be formed by 
the  leaching  of  water  soluble  substrate  from  membrane 
leaving  a  micro  porous  structure.  The  pore  former  can  be 
organic  or  inorganic  and  solid  or  liquid  in  nature.  Some 
examples  of  pore  former  are  given  below.  Alkaline  earth 
metal  salts  Sodium  chloride,  potassium  chloride,  sodium 
bromide,  potassium  phosphate.  Carbohydrate  such  as 
sucrose,  lactose,  glucose,  mannitol,  fructose  etc  is  used  as 
pore forming agent. 
Coating solvents
19  
The  primary  function  of  solvent  system  is  to  dissolved  or 
dispersed the polymer and other additive and convey them to 
substrate surface. solvent used to prepare polymeric solution 
include  inert  inorganic  and  organic  solvents  that  do  not 
adversely harm the core ,wall and other material .the various 
types  of  solvents  and  their  combinations  are  as  follows: 
Methylene  chloride,  methanol,  isopropyl  alcohol,  di-
chloromethane , ethyl acetate, acetone, carbon tetrachloride, 
cyclohexane,  butyl  alcohol,  water  etc  and  the  mixture  of 
solvents  such  as  acetone-methanol(80:20),  methylene 
chloride-  methanol  (79:21),acetone-ethanol(80:20), 
methylene chloride-methanol-water (75:22:3).  
The ideal solvent system should have following properties.  
•  It should easily and completely dissolve the polymer.  
•  It should easily disperse other coating components into 
solvent system.  Harnish Patel et al. IRJP 2012, 3 (4) 
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•  It should not give extremely viscous solution with Small 
concentration  of  polymer  (2-10%)  because  it  create 
process problem.  
•  It  should  be  odorless,  colorless,  tasteless,  inexpensive, 
nontoxic and non-irritant.  
•  It should have rapid drying rate.  
FACTORS AFFECTING DRUG RELEASE RATE
20, 21 
Solubility:  APIs  for  osmotic  delivery  should  have  water 
solubility in the desired range to get optimize drug release. 
However, by modulating the solubility of these drugs within 
the core, effective release patterns may be obtained for the 
drugs, which might otherwise appear to be poor candidate for 
osmotic delivery.  
Solubility-modifying approaches 
• Use  of  swellable  polymers:  Vinyl  Acetate  Copolymer, 
Polyethylene  Oxide  have  uniform  swelling  rate  which 
causes drug release at constant rate.  
• Use  of  wicking  agents:  These  agents  may  enhance  the 
surface area of drug with the incoming aqueous fluids. e.g. 
Colloidal  Silicon  Dioxide,  Sodium  Lauryl  Sulfate,  etc. 
Ensotrol®  technology  uses  the  same  principle  to  deliver 
drugs via osmotic mechanism.  
• Use  of  effervescent  mixtures:  Mixture  of  citric  acid  and 
sodium bicarbonate which creates pressures in the osmotic 
system and ultimately controls the release rate.  
• Use  of  Cyclodextrin  derivatives:  They  are  known  to 
increase  solubility  of  poorly  soluble  drugs.  The  same 
phenomenon can also be used for the osmotic systems.  
• Use of alternative salt form: Change in salt form of may 
change solubility.   
• Use  of  encapsulated  excipients:  Solubility  modifier 
excipient  used  in  form  of  mini-tablet  coated  with  rate 
controlling membrane.   
• Resin  Modulation  approach:  Ion-exchange  resin  methods 
are commonly used to modify the solubility of APIs. Some 
of  the  resins  used  in  osmotic  systems  are  Poly  (4-Vinyl 
Pyridine), Pentaerythritol, Citric and Adipic Acids.  
• Use of crystal habit modifiers: Different crystal form of the 
drug may have different solubility, so the excipient which 
may  change  crystal  habit  of  the  drug  can  be  used  to 
modulate  solubility.  Co-compression  of  drug  with 
excipients: Different excipients can be used to modulate the 
solubility of APIs with different mechanisms like saturation 
solubility,  pH  dependent  solubility.  Examples  of  such 
excipients are Organic acids, Buffering agent, etc. 
Osmotic pressure 
The next release-controlling factor that must be optimized is 
the  osmotic  pressure  gradient  between  inside  the 
compartment and the external environment.  
The simplest and most predictable way to achieve a constant 
osmotic  pressure  is  to  maintain  a  saturated  solution  of 
osmotic agent in the compartment.  
 
The following table shows osmotic pressure of commonly used solutes in CR formulations. 
Compound or mixture  Osmotic pump atmospheric pressure 
Sodium chloride  356 
Potassium chloride  245 
Fructose  355 
Sucrose  150 
Dextrose  82 
Potassium sulphate  39 
Mannitol  38 
Lactose-fructose  500 
Dextrose-fructose  450 
Sucrose-fructose  430 
Mannitol-fructose  415 
Lactose-sucrose  250 
Lactose-dextrose  225 
Mannitol-dextrose  225   
 
Size of delivery orifice 
To achieve an optimal zero order delivery profile, the cross 
sectional area of the orifice must be smaller than a maximum 
size  to  minimize  drug  delivery  by  diffusion  through  the 
orifice.  Furthermore,  the  area  must  be  sufficiently  large, 
above a minimum size to minimize hydrostatic pressure build 
up in the system. The typical orifice size in osmotic pumps 
ranges from 600µ to 1 mm.  
Methods  to  create  a  delivery  orifice  in  the  osmotic  tablet 
coating are  
•  Mechanical drill  
•  Laser  drill:  This  technology  is  well  established  for 
producing sub-millimeter size hole in tablets. Normally, 
CO2  laser  beam  (with  output  wavelength  of  10.6µ)  is 
used  for  drilling  purpose,  which  offers  excellent 
reliability characteristics at low costs. 
•  Indentation that is not covered during the coating process: 
Indentation  is  made  in  core  tablets  by  using  modified 
punches having needle on upper punch. This indentation 
is not covered during coating process which acts as a path 
for drug release in osmotic system.  
•  Use  of  leachable  substances  in  the  semi-permeable 
coating: e.g. controlled porosity osmotic pump 
EVALUATION OF OSMOTIC TABLET
16, 
22 
Evaluation of Powder 
•  Weight of Powder 
•  Bulk density 
•  Tapped density 
•  Carr’s index 
•  Angle of repose 
Evaluation of Osmotic tablet 
•  Hardness 
•  Thickness 
•  Friability 
•  Weight uniformity 
•  Drug content 
•  In vitro Dissolution study 
Effect of Osmotic Pressure 
Effect of  PH on drug release 
Stability study 
Curve fitting analysis 
Zero order release kinetic 
First order release kinetic Harnish Patel et al. IRJP 2012, 3 (4) 
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